BluDerma
Innotox

Medytox

Innotox

Brand

Medytox

Category

Botulinum Toxin

Origin

Korea

Options

50 unit · 100 unit

Available options

50 unit100 unit

Interested in ordering Innotox? Send an enquiry and our team will follow up with availability and pricing.

Overview

Innotox is a ready-to-use liquid botulinum toxin type A from Medytox Inc., marketed as the first pre-mixed liquid neurotoxin, eliminating the reconstitution step required by conventional lyophilised toxins. It is an animal-protein-free formulation positioned for convenience and dosing consistency in aesthetic practice.

How it works

As a type A toxin, it blocks acetylcholine release at the neuromuscular junction via SNAP-25 cleavage, temporarily relaxing the treated muscle. The mechanism and reversibility are the same as other type A toxins.

Indications

  • Glabellar (frown) lines
  • Forehead lines
  • Crow's feet
  • Masseter / jaw slimming
  • Perioral and other dynamic facial wrinkles

Key features

  • Ready-to-use pre-mixed liquid (no reconstitution)
  • Albumin-free / animal-protein-free formulation
  • Consistent, pre-set dilution
  • Available in 50 U and 100 U
  • Refrigerated storage

Benefits

  • Eliminates reconstitution and reduces preparation error
  • Consistent dosing from a standardised dilution
  • Suited to patients preferring animal-protein-free products
  • Time-saving workflow for busy clinics

Composition

Active ingredient is botulinum toxin type A supplied as a sterile pre-mixed liquid. It is an albumin-free / animal-protein-free formulation (no human serum albumin or gelatin), available in 50 U and 100 U presentations.

Usage & handling

Supplied pre-diluted as a ready-to-use liquid, so no reconstitution is required, which reduces preparation error and dilution variability. Store refrigerated at 2-8C. As with all toxins, units are product-specific and not interchangeable.

For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.